Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene

FEBS Letters

Volumn 583, Issue 10, 2009, Pages 1599-1604

  Hoda, Jean Charles ^a   Wanischeck, Mario ^b   Bertrand, Daniel ^a   Steinlein, Ortrud K ^b  

^a Medical Faculty   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CHRNA2 protein, human; CHRNA4 protein, human; Frontal lobe epilepsy; Nicotinic acetylcholine receptor

Indexed keywords

CARBAMAZEPINE; CHRNA2 PROTEIN; NICOTINE; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; NOCTURNAL SEIZURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; EPILEPSY, FRONTAL LOBE; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; OOCYTES; RECEPTORS, NICOTINIC; XENOPUS;

EID: 67349110177     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.04.024     Document Type: Article

References (18)

1. Steinlein O., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I., and Berkovic S. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11 (1995) 201-203
2. Phillips H.A., Favre I., Kirkpatrick M., Zuberi S.M., Goudie D., Heron S.E., Scheffer I.E., Sutherland G.R., Berkovic S.F., Bertrand D., and Mulley J.C. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Human Genet. 68 (2001) 225-231
3. Aridon P., Marini C., Di Resta C., Brilli E., De Fusco M., Politi F., Parrini E., Manfredi I., Pisano T., Pruna D., Curia G., Cianchetti C., Pasqualetti M., Becchetti A., Guerrini R., and Casari G. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am. J. Human Genet. 79 (2006) 342-350
4. Gu W., Bertrand D., and Steinlein O.K. A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely. Neurosci. Lett. 422 (2007) 74-76
5. Combi, R., Ferini-Strambi, L., Luisa Tenchini, M. (2007) CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. Sleep Med. doi:10.1016/j.sleep.2007.11.010.
6. Hoda, J.C., Gu, W., Friedli, M., Phillips, H., Bertrand, S., Antonarakis, S.E., Goudie, D., Roberts, R., Scheffer, I., Marini, C., Patel, J., Berkovic, S.F., Mulley, J.C., Steinlein, O.K., Bertrand, D. (2008) Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nAChR {beta}-subunit mutations outside the ion channel pore. Mol. Pharmacol. doi:10.1124/mol.107.044545.
7. Hogg R.C., Bandelier F., Benoit A., Dosch R., and Bertrand D. An automated system for intracellular and intranuclear injection. J. Neurosci. Meth. 169 (2008) 65-75
8. Revah F., Galzi J.L., Giraudat J., Haumont P.Y., Lederer F., and Changeux J.P. The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel. Proc. Natl. Acad. Sci. USA 87 (1990) 4675-4679
9. Han Z.Y., Le Novère N., Zoli M., Hill Jr. J.A., Champtiaux N., and Changeux J.P. Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur. J. Neurosci. 12 (2000) 3664-3674
10. Leniger T., Kananura C., Hufnagel A., Bertrand S., Bertrand D., and Steinlein O.K. A new CHRNA4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 44 (2003) 981-985
11. Bertrand D., Picard F., Le Hellard S., Weiland S., Favre I., Phillips H., Bertrand S., Berkovic S.F., Malafosse A., and Mulley J. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 43 Suppl. 5 (2002) 112-122
12. Bertrand D., Elmslie F., Hughes E., Trounce J., Sander T., Bertrand S., and Steinlein O.K. The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol. Dis. 20 (2005) 799-804
13. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., and Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Human Mol. Genet. 6 (1997) 943-947
14. Picard F., Bertrand S., Steinlein O.K., and Bertrand D. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine. Epilepsia 40 (1999) 1198-1209
15. Hogg R.C., and Bertrand D. Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds. Bioorg. Med. Chem. Lett. 14 (2004) 1859-1861
16. Brodtkorb E., and Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav. 9 (2006) 515-520
17. Le Novére N., Corringer P.J., and Changeux J.P. Improved secondary structure predictions for a nicotinic receptor subunit: incorporation of solvent accessibility and experimental data into a two-dimensional representation. Biophys. J. 76 (1999) 2329-2345
18. Unwin N. Nicotinic acetylcholine receptor at 9 A resolution. J. Mol. Biol. 229 (1993) 1101-1124